SAM
TVTX icon

Sectoral Asset Management’s Travere Therapeutics TVTX Stock Holding History

Sectoral Asset Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-274,623
Closed -$2.47M – 109
2023
Q4 		$2.47M Buy
+274,623
New +$2M 1.06% 32
2023
Q3 		– Sell
-435,313
Closed -$6.69M – 131
2023
Q2 		$6.69M Buy
435,313
+76,700
+21% +$1.4M 1.11% 34
2023
Q1 		$8.07M Buy
358,613
+66,293
+23% +$1.41M 1.55% 20
2022
Q4 		$6.15M Buy
292,320
+42,620
+17% +$903K 1.19% 31
2022
Q3 		$6.15M Buy
249,700
+17,700
+8% +$457K 1.21% 28
2022
Q2 		$5.62M Buy
+232,000
New +$5.83M 1.13% 38
2018
Q4 		– Sell
-10,036
Closed -$288K – 135
2018
Q3 		$288K Buy
+10,036
New +$287K 0.03% 111

Other funds holding TVTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sectoral Asset Management's TVTX Position: Q1 2024 in Review

Sectoral Asset Management sold out of Travere Therapeutics (TVTX) in Q1 2024, closing a stake of 274,623 shares — an estimated $2.47M sold.

Sectoral Asset Management first reported a position in TVTX in Q3 2018 and held it in 7 quarters. The position peaked at $8.07M in Q1 2023. 175 funds tracked by Wall St. Rank hold TVTX as of Q1 2024.

  • Sectoral Asset Management reported no remaining Travere Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 274,623 Travere Therapeutics shares in Q1 2024, an estimated $2.47M.
  • Sectoral Asset Management first reported a position in Travere Therapeutics in Q3 2018 and held it in 7 quarters.
  • Sectoral Asset Management's Travere Therapeutics position peaked at $8.07M in Q1 2023.
  • 175 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.